High throughput and computational repurposing for neglected diseases

dc.creatorHernandez, Helen W.
dc.creatorSoeung, Melinda
dc.creatorZorn, Kimberley Marie
dc.creatorAshoura, Norah
dc.creatorMottin, Melina
dc.creatorAndrade, Carolina Horta
dc.creatorCaffrey, Conor R.
dc.creatorSiqueira Neto, Jair Lage de
dc.creatorEkin, Sean
dc.date.accessioned2024-11-18T14:55:49Z
dc.date.available2024-11-18T14:55:49Z
dc.date.issued2019
dc.description.abstractPurpose Neglected tropical diseases (NTDs) represent are a heterogeneous group of communicable diseases that are found within the poorest populations of the world. There are 23 NTDs that have been prioritized by the World Health Organization, which are endemic in 149 countries and affect more than 1.4 billion people, costing these developing economies billions of dollars annually. The NTDs result from four different causative pathogens: protozoa, bacteria, helminth and virus. The majority of the diseases lack effective treatments. Therefore, new therapeutics for NTDs are desperately needed. Methods We describe various high throughput screening and computational approaches that have been performed in recent years. We have collated the molecules identified in these studies and calculated molecular properties. Results Numerous global repurposing efforts have yielded some promising compounds for various neglected tropical diseases. These compounds when analyzed as one would expect appear drug-like. Several large datasets are also now in the public domain and this enables machine learning models to be constructed that then facilitate the discovery of new molecules for these pathogens. Conclusions In the space of a few years many groups have either performed experimental or computational repurposing high throughput screens against neglected diseases. These have identified compounds which in many cases are already approved drugs. Such approaches perhaps offer a more efficient way to develop treatments which are generally not a focus for global pharmaceutical companies because of the economics or the lack of a viable market. Other diseases could perhaps benefit from these repurposing approaches.
dc.identifier.citationHERNANDEZ, Helen W. et al. High throughput and computational repurposing for neglected diseases. Pharmaceutical Research, Stuttgard, v. 36, n. 2, e27, 2019. DOI: 10.1007/s11095-018-2558-3. Disponível em: https://link.springer.com/article/10.1007/s11095-018-2558-3. Acesso em: 23 out. 2024.
dc.identifier.doi10.1007/s11095-018-2558-3
dc.identifier.issn0724-8741
dc.identifier.issne- 1573-904X
dc.identifier.urihttps://link.springer.com/article/10.1007/s11095-018-2558-3
dc.language.isoeng
dc.publisher.countryAlemanha
dc.publisher.departmentFaculdade de Farmácia - FF (RMG)
dc.rightsAcesso Restrito
dc.titleHigh throughput and computational repurposing for neglected diseases
dc.typeArtigo

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: